{"name":"Climb Bio, Inc.","slug":"climb-bio-inc","ticker":"","exchange":"","domain":"climbbio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxPcndzNDA2djFaRWZOZjBWQkhsYmZPM053bHR0TE9HSk1QU2t1N2M4clY3ZXhLWVlqVzhzT1lpakZSSFBLTi1sNl9yZ3lLWDZSZHlxbElVblBZRUtNV2N5X2Zoa3BXTjJ6bURxZUdxYjVjRkJZaHRCa1ZMNHV0am5KejYxMS1ta1I1Zy1YM3piSjNZbDZQbEpuUThWYWgyVWRPSVFXc3RfY2tkQjhKSDlFczJiOTNuaUdlSEZ0bU5jWTJYZEZkXy05VTNVSUNjclFOZmxFalBqd0tHLW5vZEh1ekZTV3U1allGU1FZUlh5SWphb2FoUTNtV1hhdHZhN2w1dGFLRw?oc=5","date":"2026-04-08","type":"pipeline","source":"GlobeNewswire","summary":"Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026 - GlobeNewswire","headline":"Climb Bio to Host R&D Spotlight Webcast Highlighting Budoprutug and the CD19 Opportunity on May 5, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOWGdOdXNWdDIzcnpJU0x6cElQcTFTU0o1Vk9mXy1ueWF5R3E0OUZyODJMQ2Z2NEN3d2NBd3A5WjFVN2UwYlMwYWJVT2RSckRab0dhaFZodFFjbmRLcUxDMjUxNUdicmp2cXlRT1lQc3k5ZVBVaEtyeXlHNDM5Q2lya3Jyd3RsemYxRUxVbGc5S2pROFNXbEh3ckFIUVJpaTJCS2I2TWFNLTZnZ2QySnc5aDN5dWxKRXI1LW81R0VDTQ?oc=5","date":"2026-04-08","type":"pipeline","source":"Stock Titan","summary":"Climb Bio’s May 5 webcast maps budoprutug’s path in 3 diseases - Stock Titan","headline":"Climb Bio’s May 5 webcast maps budoprutug’s path in 3 diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNUDd2VmdEUFhsVmpDREd6Mk5ESUZneGcwNFozQnlpdGFDd0ZpM1M1OFlTMno5VzcxSjE4T04xMVZnb0Q5RXpBNDJrZHVMUkVEb083bmdYamp5VlkxaEwtQ1IzS2RsZlJTZExzWkFBV1ZVWnBNdVJNakM5QVBxSmRYaVZCcXNOYXBlQnk5bkhfTEk0ajBDTzQ4SDljWTJLa1VBbW42bENpaHVYOEx3bmlEOTZSMEsydGVZUDFUSlF4cWtod3JvTHpMczBqMDMtNjBGSGpxeEpvNlBzUnpLWTZWVFpRb3RCVmk5R1JnRVhVRkRrOEw0MmFraWJ1cHBtY1RjdzZDdkdQNlBpYy1TU0xXeFpCSQ?oc=5","date":"2026-04-07","type":"regulatory","source":"GlobeNewswire","summary":"Climb Bio Announces FDA Fast Track Designation for - GlobeNewswire","headline":"Climb Bio Announces FDA Fast Track Designation for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQM3lpQjZNWWlTOWNtRWJwUGxnVWFRblNfNUxnWG5laGtfYlNvRzhhbnF3MnJ2Rmo1UkhqVUh1OTluZVNocEVtd2RRVWtKY2FBaWdEam9pSmtCTU5Pb3V2VWVEQkNoZmxCVTUzM1FKemtnMGRTS3M0ckJoV3NmczdFWWJ3dlNvWVMzMWRnQV8xaHNMT2FKenNCZkJBakhFdmcz?oc=5","date":"2026-04-06","type":"pipeline","source":"Yahoo Finance UK","summary":"Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight - Yahoo Finance UK","headline":"Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options |","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNUXNfWWlNbk5fSDdSMUtBZUVEWGlLV05zOXBuYXhGVmpyUE9MZWxOZzh6R2h1b3ljOFBndU1BT2FlSTZVMUp2RjFBQUhxTmNEUmdvTlRqRFVaZ2tYc0p2UUFCMDNCcThwbExNcE5idzJGcjhyZFgtSF84V0pDSFZGT2pCU3lZeXJJS1RVRks2UHhJTU5aQ3pSSHBLZ0x0RWdGME1iMF9hbW15RUJWc0RZOHExdGxnbGNZMTNUWkdSdHQ4UVQ3azE4Mk9RRDZuVi1DUTdyY1V0aV9aQQ?oc=5","date":"2026-04-04","type":"pipeline","source":"Investing.com","summary":"Climb Bio announces departure of finance SVP and appointment of new accounting officer - Investing.com","headline":"Climb Bio announces departure of finance SVP and appointment of new accounting officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPVzlPMHZiZTVVdmJRNm13b1g4VmRxT0pkbGV1SWpyaDloWGQydDRJZTYyeE5na3BtcVd2VEtyWjFpOGd6TlVTNmJVNlF0ZlNHY1Jza1pYM2hOcnNCSFZqS1FoUDhPZzh6a1hfS2otNUZXMjF5MGFaQTlyX2RZaENVMU5zTkZGb3RjOThpd0JkUHNreV81SUlLckQzR3AtRmFmX25iaFFuOVNFM1pDZWtmUHM1a2N0UQ?oc=5","date":"2026-04-03","type":"pipeline","source":"TipRanks","summary":"Climb Bio Consolidates Financial Leadership After SVP Departure - TipRanks","headline":"Climb Bio Consolidates Financial Leadership After SVP Departure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNc19mWEl2S1lMVnhWbnVjbVJQUl9pVThncjVLR3B5Wmlta2pCV210NklGcHotSkZ2MlR3VkFYNFhLenAyVnhTd0RMTFVkeURvby1laFE1Z2VLbHFnUjhjaWNHYWJjZHlsS2FTdF9DLUxlOE1BNENicmJ1Q2ZHVGF5NW8wR3BiNm45VjdUNVBmckJrWUNCazJDeU5ZVzdJN3NQekVIRQ?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Climb Bio (CLYM) consolidates CFO and principal accounting officer roles - Stock Titan","headline":"Climb Bio (CLYM) consolidates CFO and principal accounting officer roles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5hcnNQRmNNQ05zX21jUXBCa3ZERWhxczdiMHVnQTF1SklZS2dlSktoX0RKSi01UlJyNjMybkdwU283VEJvcGNwSkNMd1lLXzVmOWMxM1pRZjNUOGg0?oc=5","date":"2026-02-25","type":"trial","source":"Finimize","summary":"Climb Bio’s Stock Run Puts All Eyes On 2026 Trial Data - Finimize","headline":"Climb Bio’s Stock Run Puts All Eyes On 2026 Trial Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPVzB3U0dtYVZZbFp5bWxJaHRWdVpzLWlUNnZpZzc3cTZHY1NLY1gzN1dJZ1cyMFU4RnJSMHpiX1RJNkZmckRBaW9CTXp2V25lSEN0SEdfYm9vdXgxZ25EdHY4RTZfSWxFWkxnc0ZjZUh5QmY1bEw0bjFXQ3FDMzVCREZjaEpTcEM4ZVVBTTMtTnpHUzBuRjBPU1ZrNTg?oc=5","date":"2026-02-05","type":"pipeline","source":"Stock Titan","summary":"Biotech Climb Bio to field questions at Guggenheim, Oppenheimer, Leerink events - Stock Titan","headline":"Biotech Climb Bio to field questions at Guggenheim, Oppenheimer, Leerink events","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOMWJvbVNvQjFMRnVfb1JnQ0tHZGdLWVJVVjRHVzYxSUppYWdVdmM2Q21DWVF3UVFxc2xfOGFRamM1U0F2UmlBWGYwSUNaQmw0dlREMElidURjNjBqdkNEMU54V2htTFdqUXdldnpTeHV5NVNzOXQwaWZFVGV6WlNySWVVYm9pNDBnYnRYQ0EzV0xKU2ZtcTJZYXZwa2hxSkEyNXhFNXVXVlBxWnhSd2ZjZUtEczJwSjVsQ01qeGlhU2xfN0tJU3BnX3QteG9ENXRYV1YyUmtINnFHV1nSAeABQVVfeXFMT25ORzVsTGpOMjAtRnVQWDViYXphTlhGbDM3UGgzcFRuMG1FSFlvMWx4RVJPSzJOOWh2OFZjR2NEUjlqZHVyamI2eGxtZ3EyS0NGLTNCQ25lUUJLX2g5R0k1V0RwMkVPUGNkeXUwYVZ1clg1TGRPMFdVWkoxOHVRMjIzd09NZ05QZGVWYjQ1RHZjUHpONDNzQkcySVF1ZElwUE9pQTRxQThBOVQ0aHlhQUM4MVRZRnlMcFhhZmpPSGNXNjVwaTN2SEpZZmNMT0lkbmgwRHd1ejI4V0E2SFRnRno?oc=5","date":"2025-12-28","type":"pipeline","source":"simplywall.st","summary":"Retail investors in Climb Bio, Inc. (NASDAQ:CLYM) are its biggest bettors, and their bets paid off as stock gained 15% last week - simplywall.st","headline":"Retail investors in Climb Bio, Inc. (NASDAQ:CLYM) are its biggest bettors, and their bets paid off as stock gained 15% l","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQRThoSE5oRWpsQzdDVEZrZEhHR0d0TnZwYXZNM3NhYkVzLVR4SWlYcXprQUVxd1EyTDdWSVljY2h1SGgyN0F4czFQbFBabk0wSUFDeWNPR2N6d2pUM3ZiVzJxbU11VXZpbENKbXZZVWtSV3o3clZZemFTb0JzTFljM2lkMDcyRXc?oc=5","date":"2025-12-01","type":"pipeline","source":"BioSpace","summary":"6 Companies Hanging On in Cell Therapy - BioSpace","headline":"6 Companies Hanging On in Cell Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFAzbENMdVFncEwwOWtETlhUTnd1M2NURTlJbEowNS1ZRjNKT2t5S3N4ZWplc2NzSzFQandnZ2VjWnVvZ3MwaExMOFZIbnJOTURCTHVIWmVkQmNPc3I2OUhTQUlqQmEwUk1OeVlxZ0tRaWVkNjZXV01PUkhZczg?oc=5","date":"2025-10-21","type":"pipeline","source":"Yahoo Finance","summary":"Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy - Yahoo Finance","headline":"Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}